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Abstract
Background: Hepcidin, a key regulator of iron homeostasis, is increased in response to inflammation and some infections,
but the in vivo role of hepcidin, particularly in children with iron deficiency anemia (IDA) is unclear. We investigated the
relationships between hepcidin, cytokines and iron status in a pediatric population with a high prevalence of both anemia
and co-morbid infections.
Methodology/Principal Findings: African refugee children ,16 years were consecutively recruited at the initial post-
resettlement health check with 181 children meeting inclusion criteria. Data on hematological parameters, cytokine levels
and co-morbid infections (Helicobacter pylori, helminth and malaria) were obtained and urinary hepcidin assays performed.
The primary outcome measure was urinary hepcidin levels in children with and without iron deficiency (ID) and/or ID
anaemia (IDA). The secondary outcome measures included were the relationship between co-morbid infections and (i) ID
and IDA, (ii) urinary hepcidin levels and (iii) cytokine levels. IDA was present in 25/181 (13.8%). Children with IDA had
significantly lower hepcidin levels (IDA median hepcidin 0.14 nmol/mmol Cr (interquartile range 0.05–0.061) versus non-IDA
2.96 nmol/mmol Cr, (IQR 0.95–6.72), p,0.001). Hemoglobin, log-ferritin, iron, mean cell volume (MCV) and transferrin
saturation were positively associated with log-hepcidin levels (log-ferritin beta coefficient (b): 1.30, 95% CI 1.02 to 1.57) and
transferrin was inversely associated (b: 20.12, 95% CI 20.15 to 20.08). Cytokine levels (including IL-6) and co-morbid
infections were not associated with IDA or hepcidin levels.
Conclusions/Significance: This is the largest pediatric study of the in vivo associations between hepcidin, iron status and
cytokines. Gastro-intestinal infections (H. pylori and helminths) did not elevate urinary hepcidin or IL-6 levels in refugee
children, nor were they associated with IDA. Longitudinal and mechanistic studies of IDA will further elucidate the role of
hepcidin in paediatric iron regulation.
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Introduction
Iron deficiency anemia (IDA) is one of the commonest nutritional
deficiencies globally, with young children, women of childbearing age
and pregnant women at highest risk [1]. Adequate iron stores are
important for normal childhood growth and development [1] and
IDAmay impair cognitive development [2,3]. Nutritional deficiencies
are particularly prevalent in resettled pediatric refugees, who often
have significant co-morbidities (including acute chronic infection
and/or hemoglobinopathies) which may exacerbate IDA [4].
Hepcidin, a type II acute phase peptide, plays a central role in
the regulation of iron homeostasis [5,6]. Abnormal hepcidin levels
have been linked to anemia of chronic disease (ACD) and
hemochromatosis [6]. Hepcidin production is driven by pro-
inflammatory cytokines, particularly interleukin-6 (IL-6) [7]. It has
been proposed that the refractory IDA associated with Helicobacter
pylori infection may be mediated by inflammation-driven hepcidin
production [8]. There are few in vivo human data, particularly in
children, to substantiate these putative roles of hepcidin in either
IDA or in infections.
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We explored associations between IDA, urinary hepcidin and
cytokine levels in a pediatric population with a high prevalence of
infections, including H. pylori and Plasmodium falciparum. The
primary aim was to assess hepcidin levels in refugee children in
whom a high prevalence of IDA and H. pylori infection was
expected. The secondary aim was to investigate the effect of co-
morbid infections on (i) ID and IDA, (ii) urinary hepcidin levels
and (iii) cytokine levels. We hypothesized that children with H.
pylori infection would have a higher prevalence of IDA, higher
urinary hepcidin levels and increased inflammatory cytokines,
particularly of IL-6.
Methods
Study population and design
A cross-sectional study was conducted at the initial health
assessment unit responsible for screening the majority of
humanitarian refugees resettled in Western Australia (WA) [9].
The health assessment takes place over two visits, one week apart,
at a median time of six weeks post-resettlement (Dr A Thambiran,
Medical Director, Migrant Health Unit (MHU), personal
communication, 2007). African children (,16 years) were assessed
between February and November 2006 and consecutively
recruited, with informed consent obtained in the presence of
trained interpreters, as appropriate. Ethical approval was obtained
from the Women and Children’s Ethics Committee, Princess
Margaret Hospital for Children, Perth, Australia (Reference #:
EC06-04.13).
Data on age, gender, ethnicity, pre-migration and recent drug
administration, the presence of gastrointestinal symptoms (in
children $2 years) and details of menarche for pubertal girls were
obtained. Blood and urine samples were obtained at the first visit
and fecal samples at the second, as part of routine clinical care
[10]. Children were excluded if they had received antibiotics or
specific treatment for H. pylori in the preceding month, had a
diagnosis of immunodeficiency or active tuberculosis, or if H. pylori
fecal antigen testing was not performed.
Hematological analyses
Complete blood count, blood film, iron and hemoglobinopathy
studies (HPLC and genetic analyses) were performed on each child
at the initial visit. Anemia was defined as a hemoglobin
concentration less than age and gender-adjusted norms used in
our pediatric population (PathWest Laboratories, Nedlands, Perth,
WA) [11]. The reference intervals used in this study are
comparable to those of the World Health Organization (WHO)
Guidelines for anemia and iron deficiency [12]. As ferritin, an acute phase
reactant, may be elevated during co-morbid infection(s), iron
deficiency (ID) was defined as $2 abnormal age-corrected iron
parameters (iron, ferritin, transferrin and transferrin saturation).
IDA was defined as concurrent ID and anemia.
Urinary hepcidin analysis
Freshly voided urine samples were collected and 10 mL aliquots
were centrifuged at 5000 rpm for 5 minutes and frozen at 280uC
for batch analyses at the Department of Clinical Chemistry,
Radboud University, Nijmegen Medical Centre, The Netherlands.
Urinary hepcidin measurements of the bioactive hepcidin-25
isoform were performed by surface enhanced laser desorption
ionization – time of flight mass spectrometry (SELDI-TOF MS),
using a mass spectrometry method updated from Kemna et al
[13]. A synthetic hepcidin-24 peptide (Peptide international Inc,
Louisville, KY, USA) was used as an internal standard [14]. After
dissolving the lyophilized hepcidin-24 peptide in distilled water
(0.5 mM), 5 mL of the solution was added as an internal standard
to 495 mL urine sample (5 nmol), immediately followed by
application of a 5 mL sample to immobilized copper (Cu2+)
affinity capture protein chip arrays (IMAC30-Cu2+), equilibrated
with appropriate buffers according to the manufacturer’s instruc-
tions (Biorad, Hercules, CA, USA). Samples with hepcidin peak
heights .55Int were considered out of linear range and were
diluted with blank urine from a patient with juvenile hemochro-
matosis [15]. The urine hepcidin concentrations were normalized
to urine creatinine (Cr) values and are reported as nmol/mmol Cr.
Intra-assay or spot-to-spot variation of urinary hepcidin ranged
from 6.1% at 3.2 nmol to 7.3% at 1.2 nmol (n = 8). Inter-assay
variation ranged from 7.9% at 5 nmol to 10.9% at 1.0 nmol
(n = 4). The normal range for adults is 0.01–10.6 nmol/mmol Cr
(www.hepcidinanalysis.com). The lower limit of detection lay
between 0.003 and 0.037 nmol/mmol Cr.
Cytokine analyses
Peripheral blood samples for cytokine analyses were obtained
from children .2 years of age, centrifuged and serum snap-frozen
at 280uC for batch analyses. Assays for IL-6, IL-1b, tumor
necrosis factor alpha (TNFa) and interferon gamma (IFNc) were
performed using a commercial assay (High Sensitivity Human
Cytokine LINCOplex kit, Millipore, Missouri, USA) according to
the manufacturer’s instructions.
Diagnosis of infectious diseases
H. pylori infection was diagnosed using monoclonal fecal antigen
immunoassay techniques (MFAT) (Amplified IDEIATM
HpStARTM kits, Dako, Denmark and Oxoid, Australia) in
accordance with the manufacturer’s instructions and as previously
described [16]. H. pylori IgG was measured using a commercial
assay (Genesis Diagnostics HpG Screen ELISA, Cambridgeshire,
England) [17]. Helminth infection was defined by the presence
one or more of the following results: (i) positive serology for
schistosomiasis and/or strongyloidiasis, (ii) raised IgE levels
(.280 kU/L), (iii) peripheral eosinophilia ($0.76109/L) or (iv)
positive stool microscopy for ova cysts or parasites of known
pathogenic helminths. Fecal microscopy for parasites was
performed only if there was serological evidence of helminth
activity, peripheral eosinophilia or clinical indications, in accor-
dance with clinical protocols. Latent tuberculosis infection (LTBI)
was defined as children with a positive QuantiFERON-GoldTM
result (Cellestis, Carnegie, Australia), normal chest radiographs
and an absence of clinical symptoms suggestive of active TB. All
children were screened for malaria in WA with single thick and
thin blood films and rapid immunochromatographic testing for P.
falciparum malaria (Binax NOWH, Portland, USA), irrespective of
symptoms or pre-migration anti-malarial treatment.
Statistical analyses
All data were analyzed using SPSS version 14.0 for Windows
(2005 Chicago, Illinois, USA). Continuous variables were
transformed where necessary and compared using the indepen-
dent t-test or Mann-Whitney (MW) test as appropriate. Associa-
tions between categorical variables were initially analyzed using
Pearson chi-squared or Fisher’s exact tests. Log-transformation
(natural logarithm) of ferritin and urinary hepcidin was required to
normalize the distribution of these variables for regression
analyses. Logistic regression models were developed to analyze
associations with ID and IDA using clinical and demographic
factors as independent variables and adjusting for age and gender.
Linear regression models were used to evaluate the effect of age-
and gender-adjusted independent variables on log-hepcidin levels
Hepcidin, Anemia and Infection
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as a continuous dependent variable. Statistical significance was set
at the 5% level and 2-sided p-values were calculated.
Results
Characteristics of the study population
In total, 198 children were recruited with 17 subsequently
excluded (5 had received recent antibiotics, 11 did not have
MFAT performed and 1 child did not have hematological
assessment). Of the 181 children included in subsequent analyses,
93 were male (51.4%). The mean age was 8.0 years (standard
deviation (SD) 4.3 years). There were six ethnic groups with
Sudanese (33.7%), Burundian (28.7%) and Liberian (12.7%)
children predominating. Ten girls had attained menarche at a
mean age of 14.2 years (SD 1.0 years). Approximately half the
children (84/162, 51.8%) had no gastrointestinal symptoms at the
time of interview. There was no difference in symptoms in the
prevalence of symptoms in children with and without H. pylori or
helminth infections (H. pylori infected: 69/137 (50.4%) asymptom-
atic versus 68/137 (49.6%) symptomatic, p = 0.292 and helminth
infected: 40/75 (53.3%) asymptomatic versus 35/75 (46.7%),
p = 0.274 respectively).
Hematologic parameters and iron status
Hematologic characteristics of the study population are
summarized in Table 1. Fifty six children (30.9%) were anemic
and 35 (19.3%) had ID (Table 2). IDA was present in 25 of 181
children (13.8%) who were younger than non-anemic children
(6.3 years, SD 5.0 versus 8.3 years, SD 4.2, p = 0.033). There was
no gender difference in the prevalence of IDA. A third of children
(50/181) had a hemoglobinopathy with alpha thalassemia trait
(single gene deletion) (20/50), sickle cell anemia (HbS) trait (15/50)
and alpha thalassemia trait (single gene deletion)/HbS trait (7/50)
the most common findings. No child was homozygous for
thalassemia, HbS or double heterozygotes for b0 thalassemia/
HbS. Hemoglobinopathies were not associated with ID, IDA or
urinary hepcidin levels (Tables 3 and 4). None of the girls who had
attained menarche had IDA.
Logistic regression analyses were performed to assess the
relationship between a range of predictive variables and the
presence of ID and IDA (Table 3). In the adjusted model, log-
hepcidin was inversely related to ID (odds ratio (OR) 0.64, 95% CI
0.48–0.85, p= 0.002) whereas male gender significantly increased
the odds of ID (OR 3.25, 95% CI 1.10–9.62, p = 0.034). For those
with IDA, univariate analysis indicated that age (in years) and log-
hepcidin were inversely associated. In the age- and gender-
adjusted model, only lower log-hepcidin levels were significantly
associated with IDA (OR 0.37, 95% CI 0.24–0.57, p,0.001).
Urinary hepcidin analyses
Urinary hepcidin assays were performed in 147 children. The
median hepcidin level was 2.23 nmol/mmol Cr (interquartile range
(IQR) 0.83–6.17). Children with ID and IDA had significantly lower
hepcidin levels compared to those with normal hematologic
parameters (Table 2). Adjusted linear regression analyses demon-
strated that log-hepcidin was positively associated with hemoglobin,
mean cell volume (MCV), iron, log-ferritin and transferrin saturation
levels and negatively associated with transferrin (Table 4). The
presence of anemia, ID and IDA also were negatively associated with
log-hepcidin levels. Log-ferritin and log-hepcidin levels were
significantly correlated (Pearson r=0.587, p,0.001).
Infectious diseases
Pre-migration administration of albendazole (an anti-helminthic
agent) was documented in 143 children (79.0%), with the
remainder receiving empiric albendazole at the first health
assessment visit. The timing of albendazole administration did
not influence ID, IDA or hepcidin levels (Tables 3 and 4).
Helminth infections were diagnosed in 76/181 children (42.0%).
Eosinophilia was present in 24 children; 12 had positive serology/
fecal microscopy and elevated IgE levels, 5 had normal IgE levels
with positive serology, 5 had elevated IgE levels with negative
serology and only 2 had isolated eosinophilia (but had received
pre-departure albendazole therapy). Elevated IgE levels were
found in 63/181 children (34.8%). Eosinophil and IgE levels were
significantly higher in children with helminth infections (but not H.
pylori infection) (Table 5). P. falciparum malaria was detected in 16
children (8.8%) and 11 children (6.1%) had LTBI. No child with
LTBI had ID or IDA; LTBI was therefore not included as a
covariate in logistic regression analyses.
There was a high prevalence of H. pylori infection in this cohort
(148/181; 81.8%) [18]. Children with H. pylori infection were
significantly older (8.5 years (SD 4.2) versus 5.8 years (SD 4.3),
p = 0.001) and had a higher mean hemoglobin (119.5 g/L (SD
14.9) versus 112.2 g/L (SD 12.3), p = 0.010). Hematologic
parameters and cytokine levels for children with and without H.
pylori and helminth infections are shown in Table 5.
Ferritin levels were significantly higher in those children with
helminth (n= 76) and malaria infections (n= 16), but not in those
with H. pylori infection (n= 148). The median ferritin levels for
helminth, malaria andH. pylori infected versus non-infected children
were, respectively; 37.5 mg/L (IQR 22.0–51.7) versus 28.0 mg/L
(IQR 15.0–41.0), MW p=0.002; 39 mg/L (IQR 25.0–55.7) versus
Table 1. Characteristics of study population (n = 181 African
refugee children).
VARIABLE Estimate*
Age (years) 8.064.3
Gender (male) (%) 93/181 (51.4)
Breastfeeding (%) 16/181 (8.8)
Attained menarche (%) 10/88 (11.4)
Hemoglobin (g/L) 118.2614.7
Mean cell volume(fL) (IQR) 80.0 (74.0–83.5)
Iron (mmol/L) 11.865.2
Ferritin (mg/L) (IQR) 32.0 (18.0–47.0)
Transferrin (mmol/L)* (IQR) 36.0 (33.5–40.0)
Transferrin saturation (%) 16.667.9
Urinary hepcidin** (nmol/mmol Cr) (IQR) 2.2 (0.8–6.2)
IL-1b Level{ (pg/mL) (IQR) 4.5 (2.8–5.4)
IL-6 Level{ (pg/mL) (IQR) 14.7 (11.0–26.2)
TNFa Level1 (pg/mL) (IQR) 9.7 (7.5–11.8)
IFNc Level{ (pg/mL) (IQR) 22.8 (9.1–36.0)
Anemia (%) 56/181 (30.9)
Iron deficiency (%) 35/181 (19.3)
Iron deficiency anemia (%) 24/181 (13.3)
SD: standard deviation; IQR: interquartile range; %: percentage.
*values represent mean6SD, median and IQR or proportion.
**n = 147.
{n= 138.
{n= 139.
1n= 130.
doi:10.1371/journal.pone.0004030.t001
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Table 2. Comparison of hematological parameters by presence versus absence of (i) iron deficiency* and (ii) iron deficiency
anemia.
VARIABLE IRON DEFICIENCY IRON DEFICIENCY ANEMIA
ID (n =35) NON-ID (n=146) p-VALUE IDA (n=25) NON-IDA (n=156) p-VALUE
Hemoglobin (g/L)6SD 106.4618.8 121.16120.2 ,0.001 97.9612.8 121.5612.2 ,0.001
Mean cell volume (fL) (IQR) 73.0 (62.0–79.0) 80.0 (76.0–84.0) ,0.001 69.0 (60.5–74.0) 80.0 (76.0–84.0) ,0.001
Iron (mmoL/L)6SD 5.762.4 13.364.5 ,0.001 5.262.0 12.964.7 ,0.001
Ferritin (mg/L) (IQR) 13.0 (7.0–22.0) 35.0 (22.7–51.2) ,0.001 9.0 (5.0–16.5) 35.0 (22.0–49.5) ,0.001
Transferrin (mmoL/L) (IQR) 41.0 (37.0–48.0) 36.0 (33.0–39.0) ,0.001 47.0 (39.5–49.5) 36.0 (33.0–39.0) ,0.001
Transferrin saturation (%)6SD 7.063.6 18.866.8 ,0.001 6.163.1 18.267.1 ,0.001
Hepcidin (nmol/mmol Cr) (IQR) 0.3 (0.07–4.0) 2.9 (0.9–6.4) 0.004 0.1 (0.05–0.6) 3.0 (0.9–6.7) ,0.001
*ID: iron deficiency defined as the presence of $2 abnormal/low iron parameters (age and gender adjusted).
IDA: iron deficiency anemia defined as the presence of anemia and iron deficiency; SD: standard deviation; IQR: interquartile range; %: percent. Parameter estimates
represent mean6SD or median and IQR.
doi:10.1371/journal.pone.0004030.t002
Table 3. Odds ratios for clinical and hematological predictors of (i) iron deficiency* and (ii) iron deficiency anemia.
VARIABLE IRON DEFICIENCY IRON DEFICIENCY ANEMIA
Number
(ID present; %) Odds ratio 95% CI p-value
Number
(IDA present; %) Odds ratio 95% CI p-value
Age (years) 181 (35; 19.3) 0.926 0.849–1.011 0.085 181 (25; 13.8) 0.896 0.809–0.993 0.036
Gender
Female 88 (11; 12.5) reference 88 (9; 10.2) reference
Male 93 (24; 25.8) 2.435 1.112–5.333 0.026 93 (16; 17.2) 1.824 0.760–4.375 0.178
Log-hepcidin 147 (23; 15.6) 0.640 0.484–0.846 0.002 147 (15; 10.2) 0.373 0.242–0.573 ,0.001
IL-6 level (pg/mL){ 139 (23; 16.5) 1.022 0.997–1.048 0.082 139 (15; 10.8) 1.003 0.972–1.034 0.863
IL-1b level (pg/mL){ 138 (22; 15.9) 1.048 0.863–1.271 0.637 138 (14; 10.1) 1.084 0.869–1.353 0.475
TNFa level (pg/mL){ 130 (23; 17.7) 1.009 0.923–1.103 0.847 130 (15; 11.5) 1.058 0.969–1.154 0.208
IFNc level (pg/mL){ 139 (23; 16.5) 1.020 0.998–1.043 0.075 139 (15; 10.8) 1.022 0.997–1.047 0.087
Hemoglobinopathy
present{
No 127 (26; 20.5) reference 127 (18; 14.2) reference
Yes 54 (9; 16.7) 0.699 0.293–1.664 0.418 54 (7; 13.0) 0.896 0.332–2.310 0.789
H. pylori infection{
No 33 (7; 21.2) reference 33 (6; 18.2) reference
Yes 148 (28; 18.9) 0.992 0.367–2.683 0.987 148 (19; 12.8) 0.830 0.285–2.417 0.732
Helminth infection{
No 105 (21;20.0) reference 105 (15; 14.3) reference
Yes 76 (14;18.4) 1.195 0.500–2.855 0.688 76 (10; 13.2) 1.464 0.537–3.989 0.457
Malaria infection{
No 165 (32; 19.4) reference 165 (22; 13.3) reference
Yes 16 (3; 18.8) 1.026 0.265–3.976 0.970 16 (3; 18.8) 1.711 0.431–6.795 0.445
Predeparture
albdendazole{
No 38 (11; 28.9) reference 38 (7; 18.4) reference
Yes 143 (24; 16.8) 0.527 0.221–1.258 0.149 143 (18; 12.6) 0.281 0.280–2.061 0.588
*ID: iron deficiency defined as $2 abnormal iron parameters.
%: percent; 95% CI: 95 percent confidence interval.
{age- and gender-adjusted variable.
doi:10.1371/journal.pone.0004030.t003
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31 mg/L (IQR 16.0–46.5), MW p=0.046; and 32.0 mg/L (IQR
18.0–48.0) versus 32.0 mg/L (IQR 17.0–43.0), MW p=0.525.
No co-morbid infections were associated with ID, IDA or hepcidin
on regression analyses (Tables 3 and 4). Urinary hepcidin levels were
not significantly different between children with (n=69) or without
(n=78) helminth infections MW p=0.669) nor in children with
(n=125) or without (n=15) H. pylori infection (MW p=0.598).
Median hepcidin levels in children with helminth and H. pylori
infection were 2.42 nmol/mmol Cr (IQR 0.84–5.41) and 2.17 nmol/
mmol Cr (IQR 0.84–6.20), respectively (Table 5). No differences in
hepcidin levels were demonstrated in children who were H. pylori
seropositive (n=78) compared to those who were seronegative
(n=62) (data not shown). In children with malaria (n=16), median
hepcidin levels were higher (4.69 nmol/mmol Cr (IQR 0.96–9.38)
versus 2.19 nmol/mmol Cr (IQR 0.81–5.99) but this was not
significant (MW p=0.209). Eight children had a repeat urinary
hepcidin assay one month post malaria treatment (median hepcidin
1.65 nmol/mmol Cr (IQR 0.48–3.04), with the reduction in hepcidin
levels trending downwards (Wilcoxon rank sum test p=0.051).
Cytokine analyses
Serum cytokines were measured in 139 children (Table 1).
There were no significant associations between ID, IDA or
hepcidin levels and circulating IL-1b, IL-6, TNFa or IFNc
(Tables 3 and 4). IL-6 levels did not differ significantly between
children with or without H. pylori infection diagnosed by MFAT
(H. pylori infected 14.5 pg/mL (IQR 10.8–24.3) versus uninfected
16.1 pg/mL (IQR11.4–40.2), MW p=0.262) (Table 5) or by
serology (data not shown).
Discussion
This is the first in vivo study to explore the associations between
hepcidin, iron status, co-morbid infections and cytokine levels in
children. Urinary hepcidin levels were significantly lower in
children with ID and IDA. There was no relationship between
hepcidin and serum cytokine levels, H. pylori or helminth
infections. Our results support a feedback mechanism between
IDA and/or low ferritin and hepcidin secretion. The effect of
transferrin on hepcidin is likely mediated by low transferrin-bound
iron and/or anemia [6].
Hepcidin and iron deficiency parameters
ID and IDA are common in refugee children with a prevalence
of IDA similar to other non-Caucasian ethnic groups [19,20] and
higher than that in Caucasian Australian children [21]. Nutritional
deficiencies are highly prevalent in paediatric refugees resettled in
Australia [4], partly due to lack of dietary iron, prolonged
breastfeeding and/or delayed introduction of appropriate solid
foods and excessive intake of cow’s milk. All children were United
Nations High Commissioner of Refugees (UNHCR) designated
refugees, and were likely to have experienced nutritional and
socioeconomic deprivation. Additional nutritional data were not
collected as part of this study.
Many studies and guidelines define iron stores (and hence ID)
by a single low ferritin level [1,12]. Ferritin is an acute phase
reactant and thus a poor measure of iron status in populations in
whom infections are prevalent. The WHO defines ID as a ferritin
of ,30 mg/L in the presence of infection and/or a combination of
other iron parameters to increase the specificity of ID detection
[12]. In this study, the broader definition of ID took account of the
likely confounding effect of common co-morbid infections on
ferritin levels. We found that children with helminth and malaria
infections (but not H. pylori) had higher ferritin levels than
uninfected children. Children in this cohort with replete iron stores
(based on our ID definition) had median ferritin levels above
30 mg/L, in keeping with the WHO guidelines. Although iron
levels may be subject to diurnal variation, [22] samples were
collected during a relatively narrow time period (late morning to
early afternoon) and iron levels were not interpreted in isolation,
rather combined with other iron parameters.
Hepcidin is produced by hepatocytes and is rapidly cleared
from the circulation [23]. Urinary hepcidin levels correlate well
with hepatic hepcidin mRNA [24]. Three hepcidin isoforms
(hepcidin-20, -22 and -25) are excreted in urine with hepcidin-25
and -20 also found in serum [13,23,25]. Only hepcidin-25 has a
dominant role in iron regulation and is measured in mass
spectrometry analyses [13,25]. A strength of this study was the
use of an internal standard, which allowed quantitative assessment
of urinary hepcidin levels, in contrast to previously reported mass-
spectrometry based. Urine testing was chosen in preference to
serum assays as (i) it is less affected by diurnal variation, [13] and
(ii) the non-invasive nature of sampling (which was important
given the high level of past trauma in refugee children).
The role of hepcidin in iron metabolism and hepcidin
regulation is increasingly being defined [5,6,26,27,28]. However,
the majority of data are from in vitro or murine models, and in vivo
Table 4. Adjusted linear regression* analyses for log-hepcidin
levels.
Beta 95% CI SE p-value
Age (years) 20.039 20.109, 0.030 0.350 0.266
Gender (male=1) 0.454 20.071, 0.979 0.266 0.090
Hematologic parameters
Hemoglobin (g/L) 0.042 0.022, 0.063 0.010 ,0.001
Mean cell volume (fL) 0.110 0.070, 0.150 0.027 ,0.001
Iron (mMol/L) 0.064 0.011, 0.117 0.027 0.018
Log-ferritin 1.295 1.022, 1.569 0.138 ,0.001
Transferrin (mMol/L) 20.117 20.151, 20.082 0.018 ,0.001
Transferrin
saturation (%)
0.063 0.030, 0.096 0.017 ,0.001
IL-6 level (pg/mL) 20.005 20.024, 0.014 0.010 0.587
IL-1b level (pg/mL) 0.019 20.103, 0.142 0.062 0.754
TNFa level (pg/mL) 20.009 20.068, 0.051 0.030 0.770
IFNc level (pg/mL) 20.005 20.020, 0.010 0.007 0.510
Dichotomous clinical parameters (presence = 1; absence = 0)
Anemia 21.282 21.838, 20.725 0.282 ,0.001
Iron deficiency 21.361 22.054, 20.667 0.351 ,0.001
Iron deficiency anemia 22.555 23.323, 21.787 0.388 ,0.001
Hemoglobinopathy
present
20.165 20.753, 0.423 0.297 0.579
H. pylori infection{ 20.214 20.970, 0.542 0.382 0.576
H. pylori seropostivity 0.082 20.508, 0.673 0.298 0.783
Helminth infection 0.072 20.500, 0.644 0.289 0.803
Malaria infection 0.497 20.368, 1.363 0.438 0.258
Predeparture
albendazole
0.281 20.376, 0.939 0.333 0.399
*age and gender adjusted.
{H. pylori infection diagnosed using monoclonal fecal antigen methods.
Beta: Beta co-efficient; IDA: iron deficiency anemia; 95% CI: 95percent
confidence interval; SE: standard error; %: percentage.
doi:10.1371/journal.pone.0004030.t004
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human studies are largely of adult patients with hemaochroma-
tosis, [29,30] hemoglobinopathies, [31,32] chronic renal failure
[33] or infectious/inflammatory disease, [29,34,35,36] where data
cannot be extrapolated to children and/or IDA. ACD in
childhood is usually related to chronic infection (e.g. chronic
osteomyelitis, tuberculosis), or chronic inflammatory conditions
including systemic juvenile arthritis, systemic lupus erythematosus,
inflammatory bowel disease or chronic renal disease [37]. As
occurs in adults, the low serum iron levels seen in children with
ACD are accompanied by iron accumulation in tissue macro-
phages and is thought to be driven by pro-inflammatory cytokines
(IL-1 and IL-6) which up-regulate hepcidin production [37].
In iron loading anemia’s, such as thalassemia and sickle cell
anemia, hepcidin levels are related to iron burden, but are inversely
related to the inefficiency and extent of erythropoiesis[5,6,31,3] .
We demonstrated that hepcidin levels were significantly lower in
African children with IDA and correlated with ferritin levels, but are
unaffected by those with hemoglobinopathy traits.
Inter-relationship between hepcidin, IDA and H. pylori
infection
Hepcidin expression is induced by iron stores, and inflammation
(particularly IL-6) [6,24,28]. It is also down-regulated by hypoxia
and anemia, erythropoiesis [38]. Mediators such as hemojuvelin
and bone morphogenetic proteins are central to hepcidin signaling
pathways [39,40]. In humans, functional mutations of transmem-
brane serine protease 6 gene (TMPRSS6), an inhibitor of hepcidin
expression, result in inappropriately high hepcidin production and
severe and iron-refractory IDA [41].
IDA is an extra-gastrointestinal manifestation of H. pylori
infection, [42] but data on H. pylori-induced IDA are inconsistent
[43,44,45,46]. Potential mechanisms of IDA in H. pylori infection
include sequestration of iron by the bacteria by various binding
proteins and transporters (including lactoferrin [47] and FeoB
[48]), increased gastrointestinal blood loss and/or reduced iron
absorption secondary to chronic gastritis [43]. Our findings
suggest that such a phenomenon is uncommon in African children
who have a high prevalence of both IDA and H. pylori infection,
but show no relationship between the two diagnoses. We found
that anemia was not increased in those with H. pylori infection,
which also showed no relationship with hepcidin, and thus our
data do not support the proposal that hepcidin is the primary
mechanism of H. pylori-induced anemia [8].
The chronicity of H. pylori infection may be important, in
particular the onset of gastritis and/or development of complica-
tions such as peptic ulceration, which cannot be identified by
MFAT [44,49]. However it was considered unethical and
impractical to perform routine endoscopy on asymptomatic
children and we cannot comment further on the relationship
between the severity of gastritis and IDA [46,50]. Moreover, H.
pylori infection in children, in contrast to adults, results in a pre-
dominantly regulatory T-cell response in the gastric mucosa, with
local production of the counter-inflammatory cytokines trans-
forming growth factor and IL-10 [51]. The lack of association
between hepcidin and levels of circulating cytokines, measured by
a high-sensitivity assay, suggest that H. pylori-induced inflammation
does not influence iron status through increased hepcidin
production in childhood. It remains unclear whether a minority
of H. pylori-infected children develop more marked gastric
inflammation, leading to increased pro-inflammatory cytokines,
increased hepcidin production and subsequent refractory IDA
and/or ACD. However, it is unlikely that this is a widespread
mechanism of H. pylori-induced anemia in children, as previously
proposed [8].
Hepcidin and other markers of infection
The relationship between infection, inflammation and hepcidin
(which has in vitro antimicrobial activity) [23] is largely unexplored
Table 5. Comparison of hematological parameters and serum cytokine levels by presence versus absence of (i) H. pylori infection*
and (ii) helminth infection.
VARIABLE H. pylori infection Helminth infection
Positive{ Negative{ p-value Positive1 NegativeØ p-value
Hemoglobin (g/L)6SD 119.6614.9 112.2612.3 0.010 120.9614.2 116.3614.9 0.036
Mean cell volume (fL) (IQR) 80.0 (76.0–84.0) 75.0 (70.5–80.0) 0.001 80.0 (76.0–84.0) 79.0 (73.0–83.0) 0.065
Iron (mmoL/L)6SD 11.965.3 11.664.7 0.814 12.465.2 11.465.1 0.244
Ferritin (mg/L) (IQR) 32.0 (18.0–48.0) 32.0 (17.0–43.0) 0.525 37.5 (22.0–51.7) 28.0 (15.0–41.0) 0.002
Transferrin (mmoL/L) (IQR) 36.0 (33.0–41.0) 37.0 (35.0–39.5) 0.503 36.0 (33.0–40.0) 37.0 (34.0–40.5) 0.294
Transferrin saturation (%)6SD 16.768.1 15.966.8 0.586 17.467.7 16.068.0 0.241
Hepcidin (nmol/mmol Cr) (IQR) 2.2 (0.8–6.2) 3.8 (0.8–5.8) 0.598 2.4 (0.8–5.4) 2.2 (0.8–7.2) 0.669
Eosinophil level (6109/L) (IQR) 0.2 (0.1–0.4) 0.1 (0.05–0.3) 0.085 0.3 (0.1–0.7) 0.1 (0.07–0.2) ,0.001
IgE (kU/L) (IQR) 160.0 (53.5–467.0) 135.5 (29.0–433.2) 0.300 583.5 (312.7–1282.5) 60.0 (27.0–134.0) ,0.001
IL-6 level (pg/mL) (IQR) 14.5 (10.8–24.3) 16.1 (11.4–40.2) 0.262 15.8 (11.3–22.0) 14.5 (10.8–36.4) 0.771
IL-1b level (pg/mL) (IQR) 4.5 (2.9–5.3) 4.8 (2.3–6.5) 0.507 4.8 (3.0–5.6) 4.3 (2.4–5.4) 0.377
TNFa level (pg/mL) (IQR) 9.5 (7.6–11.7) 11.7 (6.9–13.5) 0.163 10.5 (7.6–12.9) 9.0 (7.2–11.7) 0.183
IFNc level (pg/mL) (IQR) 24.8 (8.3–36.4) 17.5 (11.6–33.9) 0.636 23.7 (10.9–40.7) 21.5 (7.2–34.8) 0.299
*H. pylori infection diagnosed using monoclonal fecal antigen methods.
{n= 148 (hemoglobin, MCV, eosinophil, iron, ferritin, transferrin, transferrin saturation), 145 (IgE), 125 (hepcidin), 117 (IL-6, IFNc), 116 (IL-1b), and 110 (TNFa).
{n= 33 (hemoglobin, MCV, iron, ferritin, transferrin, transferrin saturation, eosinophil), 32 (IgE), 22 (hepcidin), 22 (IL-6, IL-1b, IFNc) and 20 (TNFa).
1n= 76 (hemoglobin, MCV, iron, ferritin, transferrin, transferrin saturation, eosinophil, IgE), 69 (hepcidin), 58 (IL-6, IFNc), 57 (IL-1b, TNFa).
Øn = 105 (hemoglobin, MCV, eosinophil, iron, ferritin, transferrin, transferrin saturation), 78 (hepcidin), 102 (IgE), 81 (IL-6, IL-1b, IFNc) and 73 (TNFa).
SD: standard deviation; IQR: interquartile range; %: percent. Parameter estimates represent mean6SD or median and IQR.
doi:10.1371/journal.pone.0004030.t005
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in humans. In response to inflammation, hepcidin down-regulates
duodenal enterocyte iron absorption and macrophage iron release
by binding to ferroportin and inducing its internalization and
degradation, [52] thus decreasing extracellular bacterial access to
iron. It is postulated that bacterial lipopolysaccharide (LPS)
stimulates IL-6 production and thus up-regulates hepcidin release
leading to hypoferremia, [7,52] as reported in human endotoxemia
models [36]. We did not find any association between serum
cytokines and hepcidin levels, [7,34] although our data are cross-
sectional and cytokines have relatively short half-lives in the
circulation, both of which are limitations of this study. In
comparison, a report of two cases with Castleman’s disease
(characterized by chronic IL-6 overproduction) showed reduction
in hepcidin secretion following treatment with anti-IL-6 receptor
antibodies, suggesting that chronic stimulation and/or inflammation
may drive inappropriate hepcidin responses and thus ACD [53,54].
Malaria infection occurred in a minority, but these children had
higher median hepcidin levels than those children with helminth
or H. pylori infection. This may reflect a more marked and acute
inflammatory response in malaria than what is elicited by more
chronic infections. Our malaria cohort was small thus limiting
conclusions, however we demonstrated a non-significant trend for
elevated hepcidin levels to fall following malaria treatment. A
recent larger study of hepcidin and malaria is in agreement with
our findings [55]. Hepcidin may be up-regulated to prevent
parasite access to iron, possibly via the induction of hypoferremia
[52]. In a small study of Ghanan children with acute falciparum
malaria, log-hepcidin levels were associated with log-parasitemia
but not with hemoglobin or anemia [56].
Schistosomiasis, strongyloides, and giardiasis were the main
enteric infections identified, but none influenced either IDA or
hepcidin levels. Ancyclostoma duodenale (hookworm) infection has
been shown to increase the risk of IDA, by increasing
gastrointestinal blood loss [57]. Historically hookworm infection
is prevalent in resettled refugees, [9] however A. duodenale was not
detected in this cohort probably because of empiric anti-
helminthic therapy. It seems unlikely that hookworm will influence
hepcidin production, but the effects of anti-helminthic treatment
on hepcidin may warrant further investigation.
We found no associations between hepcidin secretion and either
circulating cytokine levels or co-morbid gastro-intestinal infections.
This may be related to both the chronicity and lack of sustained
inflammatory response to these infections as opposed to systemic
infections such as falciparum malaria. The low levels of ferritin in
H. pylori infected children, relative to those in children with
malaria, also suggests that chronic infection with H. pylori does not
result in significant or sustained systemic inflammation. The lack
of symptoms in children with H. pylori and helminth infections in
this cohort may also reflect less microbial load, less severe
infections and hence less gastrointestinal and systemic inflamma-
tion, with consequently no relationship observed between these
infections and cytokine and/or urinary hepcidin levels. In
addition, the hepcidin effects on its ferroportin-‘‘receptor’’ are
suggested to be cell- and time specific [58]. Moreover, changes in
hepcidin levels during inflammation and infections are accompa-
nied by cytokines that may also directly influence erythropoiesis
and intestinal iron uptake [59].
Conclusion
This is the largest in vivo study to date to explore the interaction
between inflammation, erythropoiesis, anemia and hepcidin
production. African refugee children resettled in Australia have
a high prevalence of ID and IDA and a high burden of infection.
Children with IDA had strongly down-regulated hepcidin
expression but this was not influenced by co-morbid gastrointes-
tinal infections and did not correlate with increased inflammatory
cytokines. Urinary hepcidin was influenced positively by ferritin
and most other hematologic parameters but negatively correlated
with transferrin levels.
These findings require confirmation in studies in other popula-
tions. Although infections in animal models and adult humans may
be useful in understanding the relationship between inflammation
and hepcidin, the data are not readily extrapolated to natural
infection in children. The burden of infection falls largely on children
in developing countries who often have multiple co-morbidities that
potentially modify hepcidin and iron. Longitudinal studies of IDA
treatment and hepcidin and cytokine responses, together with
investigation of putative intermediate mediators and consideration of
co-morbid infections, are required to further understand further the
role of hepcidin in iron regulation in children.
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